Paper Details
- Home
- Paper Details
The anti-asthmatic drug, montelukast, modifies the neurogenic potential in the young healthy and irradiated brain.
Author: BlennowKaj, BoströmMartina, ErikssonYohanna, KalmMarie, KuhnGeorg, SandeliusÅsa, ZetterbergHenrik
Original Abstract of the Article :
Brain tumors are the most common form of solid tumors in children. Due to the increasing number of survivors, it is of importance to prevent long-term treatment-induced side effects. Montelukast, a leukotriene receptor antagonist, may have the desired neuroprotective properties. The aim of the study...See full text at original site
Dr.Camel's Paper Summary Blogラクダ博士について
ラクダ博士は、Health Journal が論文の内容を分かりやすく解説するために作成した架空のキャラクターです。
難解な医学論文を、専門知識のない方にも理解しやすいように、噛み砕いて説明することを目指しています。
* ラクダ博士による解説は、あくまで論文の要点をまとめたものであり、原論文の完全な代替となるものではありません。詳細な内容については、必ず原論文をご参照ください。
* ラクダ博士は架空のキャラクターであり、実際の医学研究者や医療従事者とは一切関係がありません。
* 解説の内容は Health Journal が独自に解釈・作成したものであり、原論文の著者または出版社の見解を反映するものではありません。
引用元:
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6039496/
データ提供:米国国立医学図書館(NLM)
Montelukast: A Potential Protector Against Radiation-Induced Brain Damage?
The fight against brain tumors is a challenging one, especially in children. Radiation therapy, while effective, can have long-term side effects. This study investigates the potential neuroprotective effects of montelukast, a leukotriene receptor antagonist commonly used for asthma, against radiation-induced brain damage. It's like a quest to find a hidden oasis in the desert of radiation therapy, searching for ways to mitigate its harmful effects.
Montelukast: A Possible Shield Against Radiation Damage
The study reveals that montelukast may have neuroprotective properties, potentially reducing the damaging effects of cranial irradiation on the developing brain. The results show that montelukast treatment can reduce cell death and microglia activation in the young brain after radiation exposure. It's like finding a hidden spring of water in the desert, providing a source of protection against the harsh environment.
The Promise of Neuroprotection
This study offers a glimmer of hope for patients undergoing radiation therapy for brain tumors. Montelukast may provide a valuable tool for minimizing the harmful effects of radiation, enhancing treatment outcomes and improving the long-term quality of life for patients. This research opens up new avenues for exploring the potential of leukotriene receptor antagonists in protecting the brain from radiation damage.
Dr.Camel's Conclusion
This research is a promising step towards developing innovative strategies for protecting the brain during radiation therapy. It explores the potential of montelukast, a commonly used asthma medication, as a neuroprotective agent. The study's findings offer hope for finding new ways to mitigate the harmful effects of radiation on the developing brain, paving the way for improved treatment outcomes and a brighter future for patients battling brain tumors.
Date :
- Date Completed 2019-11-25
- Date Revised 2021-12-04
Further Info :
Related Literature
English
This site uses cookies. Visit our privacy policy page or click the link in any footer for more information and to change your preferences.